Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study.

[1]  K. Swedberg,et al.  Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy , 1993, The Lancet.

[2]  M. Gheorghiade,et al.  Optimal heart rate control for patients with chronic atrial fibrillation: are pharmacologic choices truly changing? , 1992, American heart journal.

[3]  Marcus Fi.  Use and toxicity of digitalis. , 1992 .

[4]  C. Lau,et al.  Usefulness of labetalol in chronic atrial fibrillation. , 1990, The American journal of cardiology.

[5]  J. Cleland,et al.  Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation. , 1990, British heart journal.

[6]  L. Rydén,et al.  Ventricular control and exercise performance in chronic atrial fibrillation: Effects of diltiazem verapamil☆ , 1990 .

[7]  C. Lau,et al.  Improvement in exercise performance and hemodynamics by labetalol in patients with idiopathic dilated cardiomyopathy. , 1990, American heart journal.

[8]  K Caidahl,et al.  Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. , 1989, Circulation.

[9]  V. Froelicher,et al.  Diltiazem and exercise performance in patients with chronic atrial fibrillation. , 1988, Chest.

[10]  J. Relland.  HEART VALVE REPLACEMENT AND RECONSTRUCTION , 1987 .

[11]  R. Zoble,et al.  Comparative effects of nadolol-digoxin combination therapy and digoxin monotherapy for chronic atrial fibrillation. , 1987, The American journal of cardiology.

[12]  V. Froelicher,et al.  Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation. , 1987, Journal of the American College of Cardiology.

[13]  J. Rees,et al.  Towards improved control of atrial fibrillation. , 1987, European heart journal.

[14]  T. Moreland,et al.  A comparison of verapamil and digoxin in the treatment of atrial fibrillation. , 1987, European heart journal.

[15]  U. Elkayam,et al.  Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation. , 1986, Circulation.

[16]  R. Gunnar,et al.  Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. , 1985, Circulation.

[17]  E. Kaplinsky,et al.  Verapamil improves exercise capacity in chronic atrial fibrillation: double-blind crossover study. , 1983, American heart journal.

[18]  E. Kaplinsky,et al.  Verapamil and digoxin: their respective effects on atrial fibrillation and their interaction. , 1982, The American journal of cardiology.

[19]  R Gomeni,et al.  Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man. , 1980, British journal of clinical pharmacology.

[20]  E. Kaplinsky,et al.  Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added beta adrenergic blocking agent. , 1979, The American journal of cardiology.

[21]  P. Probst,et al.  Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate in atrial fibrillation. , 1975, The American journal of cardiology.

[22]  E. Haber,et al.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. , 1969, The New England journal of medicine.